Mehtap GÖKÇE, Semra UTKU, Erdoğan BERÇİN, Berrin ÖZÇELİK

Synthesis and in Vitro Antimicrobial and Cytotoxicity Activities of 2-[(2-nitro-1-phenylalkyl)thio]benzoic Acid Derivatives

In this research 14 compounds were tested for their antimicrobial activity. The synthesis of 7 compounds corresponding to 2-[(2-nitro-1-phenyl-propyl)thio]benzoic acids 4 has not been reported before and 7 compounds corresponding to 2-[(2-nitro-1-phenyl-ethyl) thio]benzoic acid 3 were reported by our research group. The antibacterial activity of the title compounds was evaluated by 2 Gram (+) (Staphylococcus aureus, Bacillus subtilis) and 2 Gram (-)(Pseudomonas aeruginosa, Escherichia coli) microorganisms. The antifungal activity of the compounds was also determined against yeast-like fungi (Candida albicans, C. krusei). For antibacterial activity, ampicillin and for antifungal activity, fluconazole and ketoconazole have been used as reference compounds. All of the 2-[(2-nitro-1-phenyl-ethyl)thio]benzoic acid 3 derivatives were more active than the reference compound ketoconazole in the antifungal activity test. The title compounds were also screened by consecutive dilution to explore their toxicity to a Vero cell line. Except for 3d and 3e all of the compounds 3 exhibited lower toxicity than ketoconazole.

Anahtar Kelimeler:

2-[(2-nitro-1-phenylalkyl)thio]benzoic acid derivatives, b-Nitrostyrenes, Antibacterial Activity, Antifungal Activity, Cytotoxic Activity

Synthesis and in Vitro Antimicrobial and Cytotoxicity Activities of 2-[(2-nitro-1-phenylalkyl)thio]benzoic Acid Derivatives

Keywords:

2-[(2-nitro-1-phenylalkyl)thio]benzoic acid derivatives, b-Nitrostyrenes, Antibacterial Activity, Antifungal Activity, Cytotoxic Activity,

PDF

___

F. Sch¨ofer and M. Schooh, Arzneimmittel-Forsch., 8, 374-376 (1948).
O. Schales and H.A. Grafee, J. Am. Chem. Soc. 74, 4486-4490 (1952).
A.D. Xorge and S.S. Jorge, J. Am. Chem. Soc. 75, 4581-4582 (1953).
L.F. Cason, US, 3,376,340(CL. 260-562)02 Apr. 1968, Appl. 23 Nov. 1965; 3pp. Ref. Chem Abst. 70, 3507b (1968).
P. Messinger, Arch. Pharm. (Weinheim, Ger) 30(6), 458-462 (1973).
T.A. Lies and J.W. Clapp., US 4, 038, 288 (Cl. 260-329S;C07D333/00), 26 Jul 1977, Appl 127, 825, 24 Mr
; 16pp. Ref. Chem. Abst., 87 167565w (1977).
E. Ber¸cin, M. G¨ok¸ce, U. Abbaso˘glu and N. Noyanalpan, J. Fac. Pharm. Gazi, 12(2) 117-128 (1995).
E. Ber¸cin, M. G¨ok¸ce, B. ¨Oz¸celik, M. Yurtsever and N. Noyanalpan, J. Fac. Pharm. Gazi, 12(2) 173-187 (1995).
E. Ber¸cin and M. G¨ok¸ce, J. Fac. Pharm. Gazi, 13(1) 33-44 (1996).
E. Ber¸cin and S. ¨Ozg¨u¸cl¨u, J. Fac. Pharm. Gazi, 13(2) 133-142 (1996).
S. ¨Ozg¨u¸cl¨u, M. G¨ok¸ce, E. Ber¸cin, B. ¨Oz¸celik, T. Karao˘glu and N. Noyanalpan, Archiv Der Pharmazie, submitted.
M. G¨ok¸ce, B. ¨Oz¸celik, G. Bakır, T. Karao˘glu, E. Ber¸cin, and N. Noyanalpan, Arzneim-Forsch., in press.
V. Climesova, J. Koci, M. Pour, J. Stachel, K. Waisser and J. Kaustova, Eur. J. Pharm. Chem,, 37, 409-418 (2002).
J. Valdez, R. Cedillo, A. Hernandez-Campos, L.Yepez, F. Hernandez-Luis, G. Navarrete-Vazquez, A.Tapia, R. Cortes, M.Hernandez and R.Castillo, Bioorganic & Medicinal Chem. Letters, 12, 2221-2224 (2002).
T.C. K¨uhler., M. Swanson, B. Christenson, C.A. Klintenberg, B. Lamm, J. Fagerhag, G. Roberto, M. ¨Olwegard- Halvarsson, V. Shcherbuchin, T. Elebring and J.E. Sj¨ostr¨om, J. Med. Chem., 45, 4282-4299 (2002).
M. Andrzejewska, L. Yepez-Mulia, A. Tapia, R. Cedillo-Rivera, A.E. Laudy, B.J. Starosciak and Z. Kazimier- czuk, Eur. J. Pharm. Chem., 21, 323-329 (2004).
M. G¨ok¸ce, E. Ber¸cin, J. Fac. Pharm. Gazi, 13(2) 153-160 (1996).
D.E. Worral, Organic Synthesis, Coll. Volume 1, 413-415 (1941).
M. Koremura, H. Oku, T. Shono, T. Nakanishi, Takamine Kenkyusho Nempo, 13, 198-204 (1961).
a) C. Thornsberry, J. Anhalt, A.L. Barry, L. Cotton, E.H. Gerlach¨o, R.N. Jones, R.A. Norton, NCCLS, 5, b) National Committee for Clinical Laboratory Standards: method for broth dilution antifungal susceptibility testing yeast; approved standard, M27-A, 15, NCCLS, 10, VA Medical Center, Tuscon (1996).
W.E. Walker, B.A. Waisbren, R.R. Martins, G.E. Bataiyas, Am. Clin. Path. 56, 687-692 (1971).
A. Hensten-Pettersen, Int. End. J., 21, 89-99 (1988).
J.M.T. Hamilton-Miller, International Journal of Antimicrobial Agents, 23, 209-212 (2004).
M.E. Jones, J.A. Karlowsky, D.C.Draghi, C. Thornsberry, D.F. Sahm and D. Nathwani, International Journal of Antimicrobial Agents, 23, 240-246 (2004).
G. Fadda, T. Spanu, F. Ardito , C. Taddei , R. Santangelo , A. Siddu, D. Ciccaglione, International Journal of Antimicrobial Agents, 23, 254-261 (2004).
Z. Wang, T. Jian , L.T. Phan and Y.S. Or, Bioorganic & Medicinal Chemistry Letters, 14, 519-521 (2004)
J.A. Dromigny, B. Ndoye, E.A. Macondo, P. Nabeth, T. Siby and J. D.Perrier-Gros-Claude, Diagnostic Microbiology and Infectious Disease, 47, 595-600 (2003).
A.D. Russell, The Lancet Infectious Diseases, 3, 794-803 (2003).
H. Hanaki, Y. Yamaguchi, S. Nomura, I Haraga, A. Nagayama, K. Sunakawa, International Journal of Antimicrobial Agents, 23, 1-5 (2004).
H.V. Melckebeke, C. Vreuls, P. Gans, P. Filee, G. Liabres, B. Joris, and J.P. Simorre, Journal of Molecular Biology, 333, 711-720 (2003).
T. Korpimaki, J. Kurittu, M. Karp, Journal of Microbiological Methods, 53, 37-42 (2003).
L.E. Nunez, C. Mendez, A.F. Brana, G. Blanco and J.A. Salas, Chemistry & Biology, 10, 301-311(2003).
S.K. Bouchillon, D.J. Hoban, J.L. Johnson, B.M. Johnson, D.L. Butler, K.A. Saunders, L.A. Miller, and J.A. Poupard, International Journal of Antimicrobial Agents, 23, 181-196 (2004).
P. Butaye, A. Cloeckaert and S. Schwarz, International Journal of Antimicrobial Agents, 22, 205-210 (2003).
U. Odakowska-Jedynak, L. Paczek, M. Krawczyk, K. Zieniewicz, P. Nckowski, J. Pawlak, W. Patkowski, A. Skwarek and A. Paczkowska, Transplantation Proceedings, 35, 2304-2306 (2003).
Yee Y.C., Clinical Microbiology Newsletter, 25, 9-16 (2003).
M.A. Abraham, P.P. Thomas, G.T. John, V. Job, Shankar V., Jacob C. K., Transplantation Proceedings, 35, 215-216 (2003).
E.M. Abdel-Moety, F.I. Khattab, K.M. Kelani and A.M. AbouAl-Alamein, Il Farmaco, 57, 931-938 (2003).
Bonhomme-Faivre L., Forestier F., Auchere D., Soursac M., Orbach- Arbouys S., Farinotti R., International Journal of Pharmaceutics, 238, 133-137 (2002).
D. Cordoba-Diaz, M. Cordoba-Diaz, S. Awad,and M. Cordoba-Borrego, International Journal of Pharma- ceutics, 226, 61-68 (2001).
J.R. Cupp-Vickery, C. Garcia, A. Hofacre, K. McGee-Estrada, Journal of Molecular Biology, 311, 101-110 (2001).
M.E. Carroll, U C. Campbell and P. Heideman, Experimental and Clinical Psychopharmacology, 9,